Opioids
Stability and Hydrolysis of Desomorphine-Glucuronide
Analysis of Desomorphine in Urine Using Liquid Chromatography-Tandem Mass Spectrometry
Direct-Injection Mass Spectrometric Method for the Rapid Identification of Fentanyl and Norfentanyl in Postmortem Urine of Six Drug-Overdose Cases
Trace-Level Screening of Chemicals Related to Clandestine Desomorphine Production With Ambient Sampling, Portable Mass Spectrometry
The Experiences of Men with Substance Use Disorders Exiting Prison at the Height of the Opioid Crisis
Data-Independent Screening Method for 14 Fentanyl Analogs in Whole Blood and Oral Fluid Using LC-QTOF-MS
In Vitro Metabolism of Desomorphine
Assessing the Activity of Synthetic Opioid AH-7921 and U-47700 Analogs in Cloned Human Mu-Opioid Receptor Expressing Fibrosarcoma HT-1080 Cells
Desomorphine Screening Using Commercial Enzyme-Linked Immunosorbent Assays
The Use of a Prescription Drug Monitoring Program To Develop Algorithms To Identify Providers With Unusual Prescribing Practices for Controlled Substances
Accelerating Convolutional Neural Network via Structured Gaussian Scale Mixture Models: A Joint Grouping and Pruning Approach
Validation of two methods for the quantitative analysis of cocaine and opioids in biological matrices using LCMSMS
An interlaboratory study to evaluate the utility of gas chromatography-mass spectrometry and gas chromatography-infrared spectroscopy spectral libraries in the forensic analysis of fentanyl-related substances
Coinciding crises: The effects of the police legitimacy and opioid crises on the culture of a specialized drug investigation unit
A Mixed Method Evaluation of the Role of Religion in Desistance and Reentry
Prescription Opioid Resiliency and Vulnerability: A Mixed-Methods Comparative Case Study
Hyperbolic Graph Attention Network
Heterogeneous Information Network Embedding With Adversarial Disentangler
A Data-Informed Response to Emerging Drugs
The emerging drug crisis in the U.S. touches both criminal justice and public health, and experts from both fields came together at NIJ’s 2023 National Research Conference to discuss strategies and tools to fight this problem. Dr. Frances Scott, NIJ scientist and program manager, continues the conference discussion with two fellow panelists: Ciena Bayard, the Method Development and Validation Program Manager for D.C. Office of the Chief Medical Examiner, and Haley Greene, the Deputy Epidemiologist for the Central Region for the Virginia Department of Health. Read the transcript.